FZD7 and chronic myelogenous leukemia, BCR-ABL1 positive: Co-cultured CML cells with BMSCs showed up-regulated FZD7 expression, increased cell proliferation and decreased drug sensitivity, which could be reversed by FZD7 knockdown with shRNA.